Australasian Merkel Cell Carcinoma Interest Group

☀️ News: PBAC recommends broad listing for nivolumab & ipilimumab for treatment of advanced/metastatic cancer. Next step: Minister Butler’s approval to list the medicines on the PBS—unlocking wider access to life-saving treatment especially for those with rare cancers!

The I-MAT trial has enrolled 122 participants across Australia and New Zealand, surpassing its target of 120! 🎉Thanks to Prof Victoria Atkinson's team at Princess Alexandra Hospital and Dr Gareth Rivalland's team at Auckland City Hospital for enrolling the final participants 👏

Congrats to the GoTHAM Trial team at Sir Charles Gairdner Hospital, led by A/Prof Tarek Meniawy, for enrolling WA's first participant! The GoTHAM trial has 18 participants across 10 sites in Australia. #Merkelcellcarcinoma #SkinCancer #ClinicalTrials #ClinicalResearch #MCC

Merkel cell carcinoma clinical trials session, MASC Trials ASM (24 October 24) with A/Prof Alex Guminski and Dr Wen Xu presenting updates on the GoTHAM and I-MAT trials with Trevor Day, consumer sharing his story - My journey so far!

Angela Cairns, Manager at #TransplantAustralia, and mum, wife, and daughter-in-law of heart recipients is presenting ‘Transplant recipients and skin cancer: The lived experience’ at the 2024 MASC Trials ASM, 24 Oct in Sydney. Seats are limited! Register: masc.org.au/asm-2024/

@_ameliaksmit of @DaffodilCentre is presenting ‘The Sun Wise Study: A randomised controlled trial of a personalised prevention strategy among people with a history of skin cancer’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/

@ShellTaylor8 brings invaluable insights to her role as Deputy Chair of MASC Trials Consumer Advisory Panel. Hear Michelle’s talk ‘Two eyes aren’t always better than one!’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Seats are limited! Register: masc.org.au/asm-2024/

@Mal_Ameratunga is Head of Molecular Oncology and Rare Cancers @AlfredHealth. Hear Dr Ameratunga on the ‘BETTER Trial: a new treatment combination for melanoma brain metastases’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/

@navlymph is a Cancer and #Lymphoedema physiotherapist at Royal North Shore Hospital. Hear Dr Lee’s talk ‘Leg lymphoedema after melanoma surgery: A sub-study of the EAGLE FM trial’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/

@JiaJennyLiu, medical oncologist clinician-researcher @kinghorncancer, is presenting on her trial ‘NEOPECS: Neoadjuvant anti-PD1 and cetuximab in cutaneous squamous cell carcinoma’ at the 2024 MASC Trials ASM, 24 Oct 2024, Sydney. Register: masc.org.au/asm-2024/

Ana Ratapu, stage IV melanoma survivor with a clinical nursing background caring for melanoma and breast cancer patients, is presenting ‘An international journey to access a clinical trial’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/

@DrRahulLadwa presenting ACTINOPATH: A phase II open label trial of Pembrolizumab monotherapy to reduce the incidence of new keratinocyte carcinomas in patients with extensive field cancerisation’ at the 2024 MASC Trials ASM, 24 Oct 2024, Sydney. Register: masc.org.au/asm-2024/

@DrVictoriaMar is Director, Victorian Melanoma Service @AlfredHealth & a @Monash_SPHPM researcher. Hear Prof Mar’s talk ‘Artificial Intelligence assistance for screening and surveillance’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/

@AbuttonSloan brings 10 years’ advocacy experience to the fight against melanoma and skin cancer. Hear Alison’s talk ‘How consumers can inform dermatology clinical trials’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Seats are limited! Register: masc.org.au/asm-2024/

@kiakho of @UQDRC and Deputy Director @AusSSC is presenting ‘SiroSkin trial: Reducing the burden of skin cancers in organ transplant recipients’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Seats are limited! Register: masc.org.au/asm-2024/

Dr Wen Xu, senior lecturer at University of Queensland is presenting ‘Immunotherapy Merkel Adjuvant Trial (I-MAT) and Australasian Merkel Cell Carcinoma Interest Group (AMIGOs)’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/

@RachelNeale14 is a principal research fellow & Deputy Director @QIMRB_Institute Population Health Program. Hear Prof Neale on ‘The effect of sunscreen use on vitamin D production’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/

@AnthonyMJoshua Chair, @AOMA_MASC is presenting two talks ‘Uveal Melanoma Registries: Seeking to collate, catalogue and curate’ & ‘SILVER: Trial in progress’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Seats are limited! Register: masc.org.au/asm-2024/

BETTER trial is investigating new treatment combo using immunotherapy drugs & targeted radiotherapy for patients with melanoma brain metastases. Thanks to a generous donation from @AusSkinCancer Foundation, this trial is in start-up phase. masc.org.au/better/ @Mal_Ameratunga

The @MASC_Trials 2024 Annual Scientific Meeting has a session dedicated to Merkel cell carcinoma clinical trials, research advances, and consumer perspectives. Register today👇